Clinical Trial Update: Aspirin for the Prevention of Recurrent Venous Thromboembolism [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update covers aspirin being studied in Phase 2 and Phase 3 trials to prevent recurrent venous thromboembolism. The trial status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Deep Venous Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University Of Perugia | Conditions: Venous Thromboembolism, Deep Venous Thrombosis | Phase 2, Phase 3 | Status: UNKNOWN